메뉴 건너뛰기




Volumn 8, Issue 1, 2017, Pages 1884-1912

Circulating and disseminated tumor cells: Diagnostic tools and therapeutic targets in motion

Author keywords

CTCs; DTCs; EpCAM; Metastases; MICs

Indexed keywords

ANTINEOPLASTIC AGENT; CD47 ANTIGEN; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; HERMES ANTIGEN; LAPATINIB; PROGRAMMED DEATH 1 RECEPTOR; SCATTER FACTOR RECEPTOR; TRASTUZUMAB; TRASTUZUMAB EMTANSINE; TUMOR MARKER;

EID: 85009798294     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12242     Document Type: Review
Times cited : (59)

References (321)
  • 1
    • 77955015464 scopus 로고    scopus 로고
    • AACR centennial series: the biology of cancer metastasis: historical perspective
    • Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010; 70: 5649-69. doi: 10.1158/0008-5472.CAN-10-1040.
    • (2010) Cancer Res , vol.70 , pp. 5649-5669
    • Talmadge, J.E.1    Fidler, I.J.2
  • 3
    • 84933181941 scopus 로고    scopus 로고
    • FDA-approved smallmolecule kinase inhibitors
    • Wu P, Nielsen TE, Clausen MH. FDA-approved smallmolecule kinase inhibitors. Trends Pharmacol Sci. 2015; 36: 422-39. doi: 10.1016/j.tips.2015.04.005.
    • (2015) Trends Pharmacol Sci , vol.36 , pp. 422-439
    • Wu, P.1    Nielsen, T.E.2    Clausen, M.H.3
  • 4
    • 84960201655 scopus 로고    scopus 로고
    • Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
    • Wu P, Nielsen TE, Clausen MH. Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. Drug Discov Today. 2016; 21: 5-10. doi: 10.1016/j.drudis.2015.07.008.
    • (2016) Drug Discov Today , vol.21 , pp. 5-10
    • Wu, P.1    Nielsen, T.E.2    Clausen, M.H.3
  • 5
    • 77952144984 scopus 로고    scopus 로고
    • Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside
    • Kurtz JE, Dufour P. Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside. Expert Opin Biol Ther. 2010; 10: 951-8. doi: 10.1517/14712598.2010.482098.
    • (2010) Expert Opin Biol Ther , vol.10 , pp. 951-958
    • Kurtz, J.E.1    Dufour, P.2
  • 7
    • 15544377779 scopus 로고    scopus 로고
    • Moving away from the "one shoe fits all" strategy: the key to future progress in chemotherapy
    • Piccart-Gebhart MJ. Moving away from the "one shoe fits all" strategy: the key to future progress in chemotherapy. J Clin Oncol. 2005; 23: 1611-3. doi: 10.1200/JCO.2005.01.007.
    • (2005) J Clin Oncol , vol.23 , pp. 1611-1613
    • Piccart-Gebhart, M.J.1
  • 9
    • 27244460122 scopus 로고    scopus 로고
    • Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story?
    • Puglisi F, Piccart M. Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? Onkologie. 2005; 28: 547-9. doi: 10.1159/000088849.
    • (2005) Onkologie , vol.28 , pp. 547-549
    • Puglisi, F.1    Piccart, M.2
  • 11
    • 84925285931 scopus 로고    scopus 로고
    • Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences
    • Gires O, Stoecklein NH. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences. Cell Mol Life Sci. 2014. doi: 10.1007/s00018-014-1693-1.
    • (2014) Cell Mol Life Sci
    • Gires, O.1    Stoecklein, N.H.2
  • 15
    • 84957435817 scopus 로고    scopus 로고
    • Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution
    • Stoecklein NH, Fischer JC, Niederacher D, Terstappen LW. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution. Expert Rev Mol Diagn. 2015: 1-18. doi: 10.1586/14737159.2016.1123095.
    • Expert Rev Mol Diagn , vol.2015 , pp. 1-18
    • Stoecklein, N.H.1    Fischer, J.C.2    Niederacher, D.3    Terstappen, L.W.4
  • 16
    • 84925300542 scopus 로고    scopus 로고
    • Biology, detection, and clinical implications of circulating tumor cells
    • Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015; 7: 1-11. doi: 10.15252/emmm.201303698.
    • (2015) EMBO Mol Med , vol.7 , pp. 1-11
    • Joosse, S.A.1    Gorges, T.M.2    Pantel, K.3
  • 18
    • 78349294167 scopus 로고    scopus 로고
    • Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells
    • Riethdorf S, Pantel K. Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann N Y Acad Sci. 2010; 1210: 66-77. doi: 10.1111/j.1749-6632.2010.05779.x.
    • (2010) Ann N Y Acad Sci , vol.1210 , pp. 66-77
    • Riethdorf, S.1    Pantel, K.2
  • 19
    • 84887138426 scopus 로고    scopus 로고
    • Real-time liquid biopsy in cancer patients: fact or fiction?
    • Pantel K, Alix-Panabieres C. Real-time liquid biopsy in cancer patients: fact or fiction? Cancer Res. 2013; 73: 6384-8. doi: 10.1158/0008-5472.CAN-13-2030.
    • (2013) Cancer Res , vol.73 , pp. 6384-6388
    • Pantel, K.1    Alix-Panabieres, C.2
  • 20
    • 84887421660 scopus 로고    scopus 로고
    • Tumor metastasis: moving new biological insights into the clinic
    • Wan L, Pantel K, Kang Y. Tumor metastasis: moving new biological insights into the clinic. Nat Med. 2013; 19: 1450-64. doi: 10.1038/nm.3391.
    • (2013) Nat Med , vol.19 , pp. 1450-1464
    • Wan, L.1    Pantel, K.2    Kang, Y.3
  • 22
    • 52949124048 scopus 로고    scopus 로고
    • Cancer. The metastasis cascade
    • Klein CA. Cancer. The metastasis cascade. Science. 2008; 321: 1785-7. doi: 321/5897/1785 [pii]10.1126/science.1164853.
    • (2008) Science , vol.321 , pp. 1785-1787
    • Klein, C.A.1
  • 23
  • 27
    • 84948407218 scopus 로고    scopus 로고
    • Epithelial-tomesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
    • Zheng X, Carstens JL, Kim J, Scheible M, Kaye J, Sugimoto H, Wu CC, LeBleu VS, Kalluri R. Epithelial-tomesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer. Nature. 2015; 527: 525-30. doi: 10.1038/nature16064.
    • (2015) Nature , vol.527 , pp. 525-530
    • Zheng, X.1    Carstens, J.L.2    Kim, J.3    Scheible, M.4    Kaye, J.5    Sugimoto, H.6    Wu, C.C.7    LeBleu, V.S.8    Kalluri, R.9
  • 30
    • 84946821896 scopus 로고    scopus 로고
    • Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis
    • Pecqueux M, Fritzmann J, Adamu M, Thorlund K, Kahlert C, Reissfelder C, Weitz J, Rahbari NN. Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis. Oncotarget. 2015; 6: 35564-78. doi: 10.18632/oncotarget.5595.
    • (2015) Oncotarget , vol.6 , pp. 35564-35578
    • Pecqueux, M.1    Fritzmann, J.2    Adamu, M.3    Thorlund, K.4    Kahlert, C.5    Reissfelder, C.6    Weitz, J.7    Rahbari, N.N.8
  • 31
    • 84855528629 scopus 로고    scopus 로고
    • Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis
    • Rahbari NN, Bork U, Motschall E, Thorlund K, Buchler MW, Koch M, Weitz J. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012; 30: 60-70. doi: 10.1200/JCO.2011.36.9504.
    • (2012) J Clin Oncol , vol.30 , pp. 60-70
    • Rahbari, N.N.1    Bork, U.2    Motschall, E.3    Thorlund, K.4    Buchler, M.W.5    Koch, M.6    Weitz, J.7
  • 32
    • 84863629688 scopus 로고    scopus 로고
    • Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck
    • Tinhofer I, Hristozova T, Stromberger C, Keilhoiz U, Budach V. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012; 83: e685-90. doi: 10.1016/j.ijrobp.2012.02.009.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , pp. e685-e690
    • Tinhofer, I.1    Hristozova, T.2    Stromberger, C.3    Keilhoiz, U.4    Budach, V.5
  • 33
    • 84930654921 scopus 로고    scopus 로고
    • Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck
    • Tinhofer I, Konschak R, Stromberger C, Raguse JD, Dreyer JH, Johrens K, Keilholz U, Budach V. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol. 2014; 25: 2042-7. doi: 10.1093/annonc/mdu271.
    • (2014) Ann Oncol , vol.25 , pp. 2042-2047
    • Tinhofer, I.1    Konschak, R.2    Stromberger, C.3    Raguse, J.D.4    Dreyer, J.H.5    Johrens, K.6    Keilholz, U.7    Budach, V.8
  • 35
    • 84860999602 scopus 로고    scopus 로고
    • Circulating tumour cells escape from EpCAM-based detection due to epithelial-tomesenchymal transition
    • Gorges TM, Tinhofer I, Drosch M, Rose L, Zollner TM, Krahn T, von Ahsen O. Circulating tumour cells escape from EpCAM-based detection due to epithelial-tomesenchymal transition. BMC Cancer. 2012; 12: 178. doi: 1471-2407-12-178 [pii]10.1186/1471-2407-12-178.
    • (2012) BMC Cancer , vol.12 , pp. 178
    • Gorges, T.M.1    Tinhofer, I.2    Drosch, M.3    Rose, L.4    Zollner, T.M.5    Krahn, T.6    von Ahsen, O.7
  • 38
    • 84906731563 scopus 로고    scopus 로고
    • Challenges in circulating tumour cell research
    • Alix-Panabieres C, Pantel K. Challenges in circulating tumour cell research. Nat Rev Cancer. 2014; 14: 623-31. doi: 10.1038/nrc3820.
    • (2014) Nat Rev Cancer , vol.14 , pp. 623-631
    • Alix-Panabieres, C.1    Pantel, K.2
  • 40
    • 85015493202 scopus 로고    scopus 로고
    • "Liquid biopsy"-ctDNA detection with great potential and challenges
    • Ma M, Zhu H, Zhang C, Sun X, Gao X, Chen G. "Liquid biopsy"-ctDNA detection with great potential and challenges. Ann Transl Med. 2015; 3: 235. doi: 10.3978/j. issn.2305-5839.2015.09.29.
    • (2015) Ann Transl Med , vol.3 , pp. 235
    • Ma, M.1    Zhu, H.2    Zhang, C.3    Sun, X.4    Gao, X.5    Chen, G.6
  • 41
    • 84977265208 scopus 로고    scopus 로고
    • Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients
    • Kato K, Uchida J, Kukita Y, Kumagai T, Nishino K, Inoue T, Kimura M, Oba S, Imamura F. Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients. Sci Rep. 2016; 6: 29093. doi: 10.1038/srep29093.
    • (2016) Sci Rep , vol.6 , pp. 29093
    • Kato, K.1    Uchida, J.2    Kukita, Y.3    Kumagai, T.4    Nishino, K.5    Inoue, T.6    Kimura, M.7    Oba, S.8    Imamura, F.9
  • 44
    • 84879755425 scopus 로고    scopus 로고
    • Circulating tumor DNA to monitor metastatic breast cancer
    • Dawson SJ, Rosenfeld N, Caldas C. Circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013; 369: 93-4. doi: 10.1056/NEJMc1306040.
    • (2013) N Engl J Med , vol.369 , pp. 93-94
    • Dawson, S.J.1    Rosenfeld, N.2    Caldas, C.3
  • 48
  • 50
    • 84901008741 scopus 로고    scopus 로고
    • Circulating tumor cells: a multifunctional biomarker
    • Yap TA, Lorente D, Omlin A, Olmos D, de Bono JS. Circulating tumor cells: a multifunctional biomarker. Clin Cancer Res. 2014; 20: 2553-68. doi: 10.1158/1078-0432. CCR-13-2664.
    • (2014) Clin Cancer Res , vol.20 , pp. 2553-2568
    • Yap, T.A.1    Lorente, D.2    Omlin, A.3    Olmos, D.4    de Bono, J.S.5
  • 51
    • 0034867029 scopus 로고    scopus 로고
    • Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status
    • Moreno JG, O'Hara SM, Gross S, Doyle G, Fritsche H, Gomella LG, Terstappen LW. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology. 2001; 58: 386-92.
    • (2001) Urology , vol.58 , pp. 386-392
    • Moreno, J.G.1    O'Hara, S.M.2    Gross, S.3    Doyle, G.4    Fritsche, H.5    Gomella, L.G.6    Terstappen, L.W.7
  • 52
    • 6044259206 scopus 로고    scopus 로고
    • Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    • Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res. 2004; 10: 6897-904. doi: 10.1158/1078-0432.CCR-04-0378.
    • (2004) Clin Cancer Res , vol.10 , pp. 6897-6904
    • Allard, W.J.1    Matera, J.2    Miller, M.C.3    Repollet, M.4    Connelly, M.C.5    Rao, C.6    Tibbe, A.G.7    Uhr, J.W.8    Terstappen, L.W.9
  • 54
    • 77956268304 scopus 로고    scopus 로고
    • Circulating tumour cells in cancer patients: challenges and perspectives
    • Pantel K, Alix-Panabieres C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010; 16: 398-406. doi: S1471-4914(10)00096-1 [pii]10.1016/j.molmed.2010.07.001.
    • (2010) Trends Mol Med , vol.16 , pp. 398-406
    • Pantel, K.1    Alix-Panabieres, C.2
  • 55
    • 33745205864 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    • Cristofanilli M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Semin Oncol. 2006; 33: S9-14. doi: 10.1053/j.seminoncol.2006.03.016.
    • (2006) Semin Oncol , vol.33 , pp. S9-S14
    • Cristofanilli, M.1
  • 56
    • 84867535653 scopus 로고    scopus 로고
    • Challenges in the enumeration and phenotyping of CTC
    • Coumans FA, Ligthart ST, Uhr JW, Terstappen LW. Challenges in the enumeration and phenotyping of CTC. Clin Cancer Res. 2012; 18: 5711-8. doi: 10.1158/1078-0432.CCR-12-1585.
    • (2012) Clin Cancer Res , vol.18 , pp. 5711-5718
    • Coumans, F.A.1    Ligthart, S.T.2    Uhr, J.W.3    Terstappen, L.W.4
  • 57
    • 84878814203 scopus 로고    scopus 로고
    • Detection of cancer before distant metastasis
    • Coumans FA, Siesling S, Terstappen LW. Detection of cancer before distant metastasis. BMC Cancer. 2013; 13:283. doi: 10.1186/1471-2407-13-283.
    • (2013) BMC Cancer , vol.13 , pp. 283
    • Coumans, F.A.1    Siesling, S.2    Terstappen, L.W.3
  • 58
    • 84870007688 scopus 로고    scopus 로고
    • The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer
    • Pantel K, Alix-Panabieres C. The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer. Cancer Discov. 2012; 2: 974-5. doi: 10.1158/2159-8290.CD-12-0432.
    • (2012) Cancer Discov , vol.2 , pp. 974-975
    • Pantel, K.1    Alix-Panabieres, C.2
  • 59
    • 37149040822 scopus 로고    scopus 로고
    • Circulating tumor cells: detection, molecular profiling and future prospects
    • Jacob K, Sollier C, Jabado N. Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics. 2007; 4: 741-56. doi: 10.1586/14789450.4.6.741.
    • (2007) Expert Rev Proteomics , vol.4 , pp. 741-756
    • Jacob, K.1    Sollier, C.2    Jabado, N.3
  • 60
    • 67349253810 scopus 로고    scopus 로고
    • Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
    • Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat. 2009; 115: 581-90. doi: 10.1007/s10549-008-0143-x.
    • (2009) Breast Cancer Res Treat , vol.115 , pp. 581-590
    • Tewes, M.1    Aktas, B.2    Welt, A.3    Mueller, S.4    Hauch, S.5    Kimmig, R.6    Kasimir-Bauer, S.7
  • 68
    • 73449133770 scopus 로고    scopus 로고
    • Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
    • Stoecklein NH, Klein CA. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis. Int J Cancer. 2010; 126: 589-98. doi: 10.1002/ijc.24916.
    • (2010) Int J Cancer , vol.126 , pp. 589-598
    • Stoecklein, N.H.1    Klein, C.A.2
  • 69
    • 63049102497 scopus 로고    scopus 로고
    • Parallel progression of primary tumours and metastases
    • Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009; 9: 302-12. doi: 10.1038/nrc2627.
    • (2009) Nat Rev Cancer , vol.9 , pp. 302-312
    • Klein, C.A.1
  • 70
    • 52649162338 scopus 로고    scopus 로고
    • Circulating tumor cells and bone marrow micrometastasis
    • Alix-Panabieres C, Riethdorf S, Pantel K. Circulating tumor cells and bone marrow micrometastasis. Clin Cancer Res. 2008; 14: 5013-21. doi: 14/16/5013 [pii]10.1158/1078-0432.CCR-07-5125.
    • (2008) Clin Cancer Res , vol.14 , pp. 5013-5021
    • Alix-Panabieres, C.1    Riethdorf, S.2    Pantel, K.3
  • 71
    • 84877816994 scopus 로고    scopus 로고
    • Tumor cell dissemination: emerging biological insights from animal models and cancer patients
    • Kang Y, Pantel K. Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell. 2013; 23: 573-81. doi: 10.1016/j. ccr.2013.04.017.
    • (2013) Cancer Cell , vol.23 , pp. 573-581
    • Kang, Y.1    Pantel, K.2
  • 72
    • 84870055312 scopus 로고    scopus 로고
    • Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
    • Muller V, Riethdorf S, Rack B, Janni W, Fasching PA, Solomayer E, Aktas B, Kasimir-Bauer S, Pantel K, Fehm T, on behalf of the Dsg. Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study. Breast Cancer Res. 2012; 14: R118. doi: 10.1186/bcr3243.
    • (2012) Breast Cancer Res , vol.14 , pp. R118
    • Muller, V.1    Riethdorf, S.2    Rack, B.3    Janni, W.4    Fasching, P.A.5    Solomayer, E.6    Aktas, B.7    Kasimir-Bauer, S.8    Pantel, K.9    Fehm, T.10
  • 73
    • 18844450688 scopus 로고    scopus 로고
    • Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity
    • Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res. 2005; 11: 3678-85.
    • (2005) Clin Cancer Res , vol.11 , pp. 3678-3685
    • Muller, V.1    Stahmann, N.2    Riethdorf, S.3    Rau, T.4    Zabel, T.5    Goetz, A.6    Janicke, F.7    Pantel, K.8
  • 74
    • 42649100970 scopus 로고    scopus 로고
    • Detection, clinical relevance and specific biological properties of disseminating tumour cells
    • Pantel K, BrakenhoffRH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008; 8: 329-40.
    • (2008) Nat Rev Cancer , vol.8 , pp. 329-340
    • Pantel, K.1    Brakenhoff, R.H.2    Brandt, B.3
  • 75
    • 24944580714 scopus 로고    scopus 로고
    • Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapy
    • Pantel K, Woelfle U. Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapy. Biochim Biophys Acta. 2005; 1756: 53-64.
    • (2005) Biochim Biophys Acta , vol.1756 , pp. 53-64
    • Pantel, K.1    Woelfle, U.2
  • 77
    • 84882655536 scopus 로고    scopus 로고
    • Presence of EpCAMpositive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
    • Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H. Presence of EpCAMpositive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer. 2013; 133: 2165-71. doi: 10.1002/ijc.28230.
    • (2013) Int J Cancer , vol.133 , pp. 2165-2171
    • Schulze, K.1    Gasch, C.2    Staufer, K.3    Nashan, B.4    Lohse, A.W.5    Pantel, K.6    Riethdorf, S.7    Wege, H.8
  • 79
    • 84867556074 scopus 로고    scopus 로고
    • Meta-analysis of the prognostic value of circulating tumor cells in breast cancer
    • Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G, Liu J, Pantel K. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res. 2012; 18: 5701-10. doi: 10.1158/1078-0432.CCR-12-1587.
    • (2012) Clin Cancer Res , vol.18 , pp. 5701-5710
    • Zhang, L.1    Riethdorf, S.2    Wu, G.3    Wang, T.4    Yang, K.5    Peng, G.6    Liu, J.7    Pantel, K.8
  • 80
    • 84881555649 scopus 로고    scopus 로고
    • Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics
    • Onstenk W, Gratama JW, Foekens JA, Sleijfer S. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics. Cancer Treat Rev. 2013; 39: 691-700. doi: 10.1016/j.ctrv.2013.04.001.
    • (2013) Cancer Treat Rev , vol.39 , pp. 691-700
    • Onstenk, W.1    Gratama, J.W.2    Foekens, J.A.3    Sleijfer, S.4
  • 81
    • 78649467513 scopus 로고    scopus 로고
    • Does tumour dormancy offer a therapeutic target?
    • Goss PE, Chambers AF. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer. 2010; 10: 871-7. doi: 10.1038/nrc2933.
    • (2010) Nat Rev Cancer , vol.10 , pp. 871-877
    • Goss, P.E.1    Chambers, A.F.2
  • 82
    • 13944259758 scopus 로고    scopus 로고
    • The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
    • Janni W, Rack B, Schindlbeck C, Strobl B, Rjosk D, Braun S, Sommer H, Pantel K, Gerber B, Friese K. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence. Cancer. 2005; 103: 884-91.
    • (2005) Cancer , vol.103 , pp. 884-891
    • Janni, W.1    Rack, B.2    Schindlbeck, C.3    Strobl, B.4    Rjosk, D.5    Braun, S.6    Sommer, H.7    Pantel, K.8    Gerber, B.9    Friese, K.10
  • 84
    • 51649120140 scopus 로고    scopus 로고
    • Review: Biological relevance of disseminated tumor cells in cancer patients
    • Riethdorf S, Wikman H, Pantel K. Review: Biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008; 123: 1991-2006. doi: 10.1002/ijc.23825.
    • (2008) Int J Cancer , vol.123 , pp. 1991-2006
    • Riethdorf, S.1    Wikman, H.2    Pantel, K.3
  • 85
    • 67650434696 scopus 로고    scopus 로고
    • Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma
    • Klein CA, Stoecklein NH. Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma. Cancer Res. 2009; 69: 5285-8. doi: 0008-5472.CAN-08-4586 [pii]10.1158/0008-5472.CAN-08-4586.
    • (2009) Cancer Res , vol.69 , pp. 5285-5288
    • Klein, C.A.1    Stoecklein, N.H.2
  • 86
    • 0642337591 scopus 로고    scopus 로고
    • The systemic progression of human cancer: a focus on the individual disseminated cancer cell the unit of selection
    • Klein CA. The systemic progression of human cancer: a focus on the individual disseminated cancer cell the unit of selection. Adv Cancer Res. 2003; 89: 35-67.
    • (2003) Adv Cancer Res , vol.89 , pp. 35-67
    • Klein, C.A.1
  • 87
    • 44949247301 scopus 로고    scopus 로고
    • Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization
    • Riethdorf S, Pantel K. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology. 2008; 75: 140-8. doi: 000123852 [pii]10.1159/000123852.
    • (2008) Pathobiology , vol.75 , pp. 140-148
    • Riethdorf, S.1    Pantel, K.2
  • 93
    • 0018141482 scopus 로고
    • Tumor heterogeneity and the biology of cancer invasion and metastasis
    • Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res. 1978; 38: 2651-60.
    • (1978) Cancer Res , vol.38 , pp. 2651-2660
    • Fidler, I.J.1
  • 94
    • 35848964790 scopus 로고    scopus 로고
    • Breast tumor heterogeneity: cancer stem cells or clonal evolution?
    • Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle. 2007; 6: 2332-8.
    • (2007) Cell Cycle , vol.6 , pp. 2332-2338
    • Campbell, L.L.1    Polyak, K.2
  • 96
    • 63049123066 scopus 로고    scopus 로고
    • Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
    • Polyak K, Weinberg RA. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 2009; 9: 265-73. doi: 10.1038/nrc2620.
    • (2009) Nat Rev Cancer , vol.9 , pp. 265-273
    • Polyak, K.1    Weinberg, R.A.2
  • 99
    • 84887456252 scopus 로고    scopus 로고
    • The epigenetics of epithelialmesenchymal plasticity in cancer
    • Tam WL, Weinberg RA. The epigenetics of epithelialmesenchymal plasticity in cancer. Nat Med. 2013; 19: 1438-49. doi: 10.1038/nm.3336.
    • (2013) Nat Med , vol.19 , pp. 1438-1449
    • Tam, W.L.1    Weinberg, R.A.2
  • 100
    • 59449097723 scopus 로고    scopus 로고
    • How epigenetics can explain human metastasis: a new role for microRNAs
    • Lujambio A, Esteller M. How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle. 2009; 8: 377-82.
    • (2009) Cell Cycle , vol.8 , pp. 377-382
    • Lujambio, A.1    Esteller, M.2
  • 101
    • 33750616197 scopus 로고    scopus 로고
    • Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype
    • Nierodzik ML, Karpatkin S. Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell. 2006; 10: 355-62. doi: 10.1016/j.ccr.2006.10.002.
    • (2006) Cancer Cell , vol.10 , pp. 355-362
    • Nierodzik, M.L.1    Karpatkin, S.2
  • 103
    • 45949108135 scopus 로고    scopus 로고
    • Dormant tumor cells as a therapeutic target?
    • Quesnel B. Dormant tumor cells as a therapeutic target? Cancer Lett. 2008; 267: 10-7. doi: 10.1016/j. canlet.2008.02.055.
    • (2008) Cancer Lett , vol.267 , pp. 10-17
    • Quesnel, B.1
  • 104
    • 84906937205 scopus 로고    scopus 로고
    • Mechanisms of disseminated cancer cell dormancy: an awakening field
    • Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014; 14: 611-22. doi: 10.1038/nrc3793.
    • (2014) Nat Rev Cancer , vol.14 , pp. 611-622
    • Sosa, M.S.1    Bragado, P.2    Aguirre-Ghiso, J.A.3
  • 105
    • 84925669716 scopus 로고    scopus 로고
    • Metastasis prevention by targeting the dormant niche
    • Ghajar CM. Metastasis prevention by targeting the dormant niche. Nat Rev Cancer. 2015; 15: 238-47. doi: 10.1038/nrc3910.
    • (2015) Nat Rev Cancer , vol.15 , pp. 238-247
    • Ghajar, C.M.1
  • 107
    • 70450198396 scopus 로고    scopus 로고
    • Epithelialmesenchymal transitions in development and disease
    • Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell. 2009; 139: 871-90. doi: 10.1016/j.cell.2009.11.007.
    • (2009) Cell , vol.139 , pp. 871-890
    • Thiery, J.P.1    Acloque, H.2    Huang, R.Y.3    Nieto, M.A.4
  • 108
    • 84876451247 scopus 로고    scopus 로고
    • Tumor dissemination: an EMT affair
    • Thiery JP, Lim CT. Tumor dissemination: an EMT affair. Cancer Cell. 2013; 23: 272-3. doi: 10.1016/j. ccr.2013.03.004.
    • (2013) Cancer Cell , vol.23 , pp. 272-273
    • Thiery, J.P.1    Lim, C.T.2
  • 109
    • 79953147370 scopus 로고    scopus 로고
    • A perspective on cancer cell metastasis
    • Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011; 331: 1559-64. doi: 10.1126/science.1203543.
    • (2011) Science , vol.331 , pp. 1559-1564
    • Chaffer, C.L.1    Weinberg, R.A.2
  • 110
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: the next generation
    • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74. doi: S0092-8674(11)00127-9 [pii]10.1016/j.cell.2011.02.013.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 111
    • 0032962333 scopus 로고    scopus 로고
    • Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease
    • Braun S, Hepp F, Sommer HL, Pantel K. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer. 1999; 84: 1-5. doi:
    • (1999) Int J Cancer , vol.84 , pp. 1-5
    • Braun, S.1    Hepp, F.2    Sommer, H.L.3    Pantel, K.4
  • 114
    • 27144488136 scopus 로고    scopus 로고
    • Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer
    • Weigelt B, Hu Z, He X, Livasy C, Carey LA, Ewend MG, Glas AM, Perou CM, Van't Veer LJ. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005; 65: 9155-8. doi: 10.1158/0008-5472.CAN-05-2553.
    • (2005) Cancer Res , vol.65 , pp. 9155-9158
    • Weigelt, B.1    Hu, Z.2    He, X.3    Livasy, C.4    Carey, L.A.5    Ewend, M.G.6    Glas, A.M.7    Perou, C.M.8    Van't Veer, L.J.9
  • 115
    • 12144286892 scopus 로고    scopus 로고
    • Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis
    • Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y, Zhang SW, Wang H, Wu C, Wang H, Fuller GN, Symmans WF, Shmulevich I, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004; 100: 1110-22. doi: 10.1002/cncr.20095.
    • (2004) Cancer , vol.100 , pp. 1110-1122
    • Hao, X.1    Sun, B.2    Hu, L.3    Lahdesmaki, H.4    Dunmire, V.5    Feng, Y.6    Zhang, S.W.7    Wang, H.8    Wu, C.9    Wang, H.10    Fuller, G.N.11    Symmans, W.F.12    Shmulevich, I.13
  • 116
    • 0033957255 scopus 로고    scopus 로고
    • Reexpression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]
    • Bukholm IK, Nesland JM, Borresen-Dale AL. Reexpression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments]. J Pathol. 2000; 190: 15-9. doi: 10.1002/(SICI)1096-9896(200001)190:1<15::AIDPATH489>3.0.CO;2-L.
    • (2000) J Pathol , vol.190 , pp. 15-19
    • Bukholm, I.K.1    Nesland, J.M.2    Borresen-Dale, A.L.3
  • 117
    • 23144442644 scopus 로고    scopus 로고
    • Breast cancer metastasis: markers and models
    • Weigelt B, Peterse JL, van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005; 5: 591-602. doi: 10.1038/nrc1670.
    • (2005) Nat Rev Cancer , vol.5 , pp. 591-602
    • Weigelt, B.1    Peterse, J.L.2    van't Veer, L.J.3
  • 122
    • 84875183611 scopus 로고    scopus 로고
    • Metastasis awakening: the challenges of targeting minimal residual cancer
    • Polzer B, Klein CA. Metastasis awakening: the challenges of targeting minimal residual cancer. Nat Med. 2013; 19: 274-5. doi: 10.1038/nm.3121.
    • (2013) Nat Med , vol.19 , pp. 274-275
    • Polzer, B.1    Klein, C.A.2
  • 123
    • 0037226593 scopus 로고    scopus 로고
    • A molecular signature of metastasis in primary solid tumors
    • Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003; 33: 49-54. doi: 10.1038/ng1060.
    • (2003) Nat Genet , vol.33 , pp. 49-54
    • Ramaswamy, S.1    Ross, K.N.2    Lander, E.S.3    Golub, T.R.4
  • 124
    • 84889781527 scopus 로고    scopus 로고
    • Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis
    • Barradas AM, Terstappen LW. Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis. Cancers (Basel). 2013; 5: 1619-42. doi: 10.3390/cancers5041619.
    • (2013) Cancers (Basel) , vol.5 , pp. 1619-1642
    • Barradas, A.M.1    Terstappen, L.W.2
  • 130
    • 84880059674 scopus 로고    scopus 로고
    • CD44. can a cancer-initiating cell profit from an Cancer Res
    • Zoller M. CD44: can a cancer-initiating cell profit from an Cancer Res. 2013; 73: 4112-22. doi: 10.1158/0008-5472. CAN-12-3801.
    • (2013) , vol.73 , pp. 4112-4122
    • Zoller, M.1
  • 131
    • 77956664396 scopus 로고    scopus 로고
    • Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients
    • Nagahara M, Mimori K, Kataoka A, Ishii H, Tanaka F, Nakagawa T, Sato T, Ono S, Sugihara K, Mori M. Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients. Clin Cancer Res. 2010; 16: 4625-35. doi: 10.1158/1078-0432.CCR-10-0349.
    • (2010) Clin Cancer Res , vol.16 , pp. 4625-4635
    • Nagahara, M.1    Mimori, K.2    Kataoka, A.3    Ishii, H.4    Tanaka, F.5    Nakagawa, T.6    Sato, T.7    Ono, S.8    Sugihara, K.9    Mori, M.10
  • 132
    • 78649420006 scopus 로고    scopus 로고
    • MET signalling: principles and functions in development, organ regeneration and cancer
    • Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010; 11: 834-48. doi: 10.1038/nrm3012.
    • (2010) Nat Rev Mol Cell Biol , vol.11 , pp. 834-848
    • Trusolino, L.1    Bertotti, A.2    Comoglio, P.M.3
  • 133
    • 58849093242 scopus 로고    scopus 로고
    • On the abundance of EpCAM on cancer stem cells
    • author reply, nrc2499-c1 [pii]
    • Gires O, Klein CA, Baeuerle PA. On the abundance of EpCAM on cancer stem cells. Nat Rev Cancer. 2009; 9: 143; author reply doi: nrc2499-c1 [pii]10.1038/nrc2499-c1.
    • (2009) Nat Rev Cancer , vol.9 , pp. 143
    • Gires, O.1    Klein, C.A.2    Baeuerle, P.A.3
  • 134
    • 52549087785 scopus 로고    scopus 로고
    • Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
    • Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008; 8: 755-68. doi:
    • (2008) Nat Rev Cancer , vol.8 , pp. 755-768
    • Visvader, J.E.1    Lindeman, G.J.2
  • 135
    • 82255175072 scopus 로고    scopus 로고
    • Lessons from common markers of tumor-initiating cells in solid cancers
    • Gires O. Lessons from common markers of tumor-initiating cells in solid cancers. Cell Mol Life Sci. 2011. doi: 10.1007/s00018-011-0772-9.
    • (2011) Cell Mol Life Sci
    • Gires, O.1
  • 136
    • 67651003100 scopus 로고    scopus 로고
    • The emerging role of EpCAM in cancer and stem cell signaling
    • Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 2009; 69: 5627-9. doi: 0008-5472.CAN-09-0654 [pii]10.1158/0008-5472.CAN-09-0654.
    • (2009) Cancer Res , vol.69 , pp. 5627-5629
    • Munz, M.1    Baeuerle, P.A.2    Gires, O.3
  • 141
    • 25444495269 scopus 로고    scopus 로고
    • Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression
    • nrc1694 [pii]
    • Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer. 2005; 5: 744-9. doi: nrc1694 [pii]10.1038/nrc1694.
    • (2005) Nat Rev Cancer , vol.5 , pp. 744-749
    • Brabletz, T.1    Jung, A.2    Spaderna, S.3    Hlubek, F.4    Kirchner, T.5
  • 142
    • 33646432485 scopus 로고    scopus 로고
    • E-cadherin engagement stimulates proliferation via Rac1
    • Liu WF, Nelson CM, Pirone DM, Chen CS. E-cadherin engagement stimulates proliferation via Rac1. J Cell Biol. 2006; 173: 431-41. doi: 10.1083/jcb.200510087.
    • (2006) J Cell Biol , vol.173 , pp. 431-441
    • Liu, W.F.1    Nelson, C.M.2    Pirone, D.M.3    Chen, C.S.4
  • 143
    • 57349114162 scopus 로고    scopus 로고
    • The cell-cell adhesion molecule E-cadherin
    • van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008; 65: 3756-88. doi: 10.1007/s00018-008-8281-1.
    • (2008) Cell Mol Life Sci , vol.65 , pp. 3756-3788
    • van Roy, F.1    Berx, G.2
  • 144
    • 0037169868 scopus 로고    scopus 로고
    • Cadherins and the tumour progression: is it all in a switch?
    • Cavallaro U, Schaffhauser B, Christofori G. Cadherins and the tumour progression: is it all in a switch? Cancer Lett. 2002; 176: 123-8.
    • (2002) Cancer Lett , vol.176 , pp. 123-128
    • Cavallaro, U.1    Schaffhauser, B.2    Christofori, G.3
  • 145
    • 84943425036 scopus 로고    scopus 로고
    • Morphological and immunohistochemical identification of epithelialto-mesenchymal transition in clinical prostate cancer
    • Kolijn K, Verhoef EI, van Leenders GJ. Morphological and immunohistochemical identification of epithelialto-mesenchymal transition in clinical prostate cancer. Oncotarget. 2015; 6: 24488-98.
    • (2015) Oncotarget , vol.6 , pp. 24488-24498
    • Kolijn, K.1    Verhoef, E.I.2    van Leenders, G.J.3
  • 146
    • 84876089304 scopus 로고    scopus 로고
    • E-cadherinintegrin crosstalk in cancer invasion and metastasis
    • Canel M, Serrels A, Frame MC, Brunton VG. E-cadherinintegrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013; 126: 393-401. doi: 10.1242/jcs.100115.
    • (2013) J Cell Sci , vol.126 , pp. 393-401
    • Canel, M.1    Serrels, A.2    Frame, M.C.3    Brunton, V.G.4
  • 148
    • 24644451986 scopus 로고    scopus 로고
    • Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors
    • Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Jr., Terstappen LW. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Int J Oncol. 2005; 27: 49-57.
    • (2005) Int J Oncol , vol.27 , pp. 49-57
    • Rao, C.G.1    Chianese, D.2    Doyle, G.V.3    Miller, M.C.4    Russell, T.5    Sanders, R.A.6    Terstappen, L.W.7
  • 152
    • 84906936120 scopus 로고    scopus 로고
    • Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells
    • Kim MJ, Choi NY, Lee EK, Kang MS. Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells. Cell Oncol (Dordr). 2014; 37: 235-43. doi: 10.1007/s13402-014-0178-4.
    • (2014) Cell Oncol (Dordr) , vol.37 , pp. 235-243
    • Kim, M.J.1    Choi, N.Y.2    Lee, E.K.3    Kang, M.S.4
  • 154
    • 84860367617 scopus 로고    scopus 로고
    • EpCAM and its potential role in tumor-initiating cells
    • 18953 [pii]
    • Imrich S, Hachmeister M, Gires O. EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr. 2012; 6: 30-8. doi: 18953 [pii]10.4161/cam.18953.
    • (2012) Cell Adh Migr , vol.6 , pp. 30-38
    • Imrich, S.1    Hachmeister, M.2    Gires, O.3
  • 156
    • 55949111134 scopus 로고    scopus 로고
    • A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators
    • Maaser K, Borlak J. A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators. Br J Cancer. 2008; 99: 1635-43. doi:
    • (2008) Br J Cancer , vol.99 , pp. 1635-1643
    • Maaser, K.1    Borlak, J.2
  • 159
    • 79960936439 scopus 로고    scopus 로고
    • Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative
    • Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, Emich H, Costea DE, Mackenzie IC. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res. 2011; 71: 5317-26. doi: 0008-5472.CAN-11-1059 [pii]10.1158/0008-5472.CAN-11-1059.
    • (2011) Cancer Res , vol.71 , pp. 5317-5326
    • Biddle, A.1    Liang, X.2    Gammon, L.3    Fazil, B.4    Harper, L.J.5    Emich, H.6    Costea, D.E.7    Mackenzie, I.C.8
  • 160
    • 78049514693 scopus 로고    scopus 로고
    • The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling
    • Maghzal N, Vogt E, Reintsch W, Fraser JS, Fagotto F. The tumor-associated EpCAM regulates morphogenetic movements through intracellular signaling. J Cell Biol. 2010; 191: 645-59. doi: jcb.201004074 [pii]10.1083/jcb.201004074.
    • (2010) J Cell Biol , vol.191 , pp. 645-659
    • Maghzal, N.1    Vogt, E.2    Reintsch, W.3    Fraser, J.S.4    Fagotto, F.5
  • 161
    • 84887615793 scopus 로고    scopus 로고
    • EpCAM controls actomyosin contractility and cell adhesion by direct inhibition of PKC
    • Maghzal N, Kayali HA, Rohani N, Kajava AV, Fagotto F. EpCAM controls actomyosin contractility and cell adhesion by direct inhibition of PKC. Dev Cell. 2013; 27: 263-77. doi: 10.1016/j.devcel.2013.10.003.
    • (2013) Dev Cell , vol.27 , pp. 263-277
    • Maghzal, N.1    Kayali, H.A.2    Rohani, N.3    Kajava, A.V.4    Fagotto, F.5
  • 163
    • 59149084182 scopus 로고    scopus 로고
    • Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion
    • Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE. Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion. Cancer Res. 2009.
    • (2009) Cancer Res
    • Sankpal, N.V.1    Willman, M.W.2    Fleming, T.P.3    Mayfield, J.D.4    Gillanders, W.E.5
  • 164
    • 4143065769 scopus 로고    scopus 로고
    • The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
    • Munz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O. The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene. 2004; 23: 5748-58.
    • (2004) Oncogene , vol.23 , pp. 5748-5758
    • Munz, M.1    Kieu, C.2    Mack, B.3    Schmitt, B.4    Zeidler, R.5    Gires, O.6
  • 165
    • 33846804010 scopus 로고    scopus 로고
    • EpCAM (CD326) finding its role in cancer
    • Baeuerle PA, Gires O. EpCAM (CD326) finding its role in cancer. Br J Cancer. 2007; 96: 417-23.
    • (2007) Br J Cancer , vol.96 , pp. 417-423
    • Baeuerle, P.A.1    Gires, O.2
  • 166
    • 60649111501 scopus 로고    scopus 로고
    • EpCAM: Another Surface-to-Nucleus Missile
    • Carpenter G, Red Brewer M. EpCAM: Another Surface-to-Nucleus Missile. Cancer Cell. 2009; 15: 165-6. doi: S1535-6108(09)00038-5 [pii]10.1016/j.ccr.2009.02.005.
    • (2009) Cancer Cell , vol.15 , pp. 165-166
    • Carpenter, G.1    Red Brewer, M.2
  • 167
    • 85009755184 scopus 로고    scopus 로고
    • Journey into the center of the cell
    • Pickersgill H. Journey into the center of the cell. Science. 2009; 323.
    • (2009) Science , pp. 323
    • Pickersgill, H.1
  • 168
    • 77950571597 scopus 로고    scopus 로고
    • Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells
    • Lu TY, Lu RM, Liao MY, Yu J, Chung CH, Kao CF, Wu HC. Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells. J Biol Chem. 2010; 285: 8719-32. doi: M109.077081 [pii]10.1074/jbc. M109.077081.
    • (2010) J Biol Chem , vol.285 , pp. 8719-8732
    • Lu, T.Y.1    Lu, R.M.2    Liao, M.Y.3    Yu, J.4    Chung, C.H.5    Kao, C.F.6    Wu, H.C.7
  • 170
    • 69249092641 scopus 로고    scopus 로고
    • EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype
    • Gonzalez B, Denzel S, Mack B, Conrad M, Gires O. EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype. Stem Cells. 2009; 27: 1782-91. doi: 10.1002/stem.97.
    • (2009) Stem Cells , vol.27 , pp. 1782-1791
    • Gonzalez, B.1    Denzel, S.2    Mack, B.3    Conrad, M.4    Gires, O.5
  • 171
  • 172
    • 84876870029 scopus 로고    scopus 로고
    • Filtration parameters influencing circulating tumor cell enrichment from whole blood
    • Coumans FA, van Dalum G, Beck M, Terstappen LW. Filtration parameters influencing circulating tumor cell enrichment from whole blood. PLoS One. 2013; 8: e61774. doi: 10.1371/journal.pone.0061774.
    • (2013) PLoS One , vol.8
    • Coumans, F.A.1    van Dalum, G.2    Beck, M.3    Terstappen, L.W.4
  • 173
    • 84944474550 scopus 로고    scopus 로고
    • Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells
    • Ge F, Zhang H, Wang DD, Li L, Lin PP. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells. Oncotarget. 2015; 6: 27049-64. doi: 10.18632/oncotarget.4819.
    • (2015) Oncotarget , vol.6 , pp. 27049-27064
    • Ge, F.1    Zhang, H.2    Wang, D.D.3    Li, L.4    Lin, P.P.5
  • 174
    • 84934342479 scopus 로고    scopus 로고
    • Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model
    • Jiang J, Wang DD, Yang M, Chen D, Pang L, Guo S, Cai J, Wery JP, Li L, Li HQ, Lin PP. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model. Oncotarget. 2015; 6: 15639-51. doi: 10.18632/oncotarget.3712.
    • (2015) Oncotarget , vol.6 , pp. 15639-15651
    • Jiang, J.1    Wang, D.D.2    Yang, M.3    Chen, D.4    Pang, L.5    Guo, S.6    Cai, J.7    Wery, J.P.8    Li, L.9    Li, H.Q.10    Lin, P.P.11
  • 175
    • 84907081286 scopus 로고    scopus 로고
    • Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer
    • Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M, Zhang Q, Cao Y, Wang DD, Lin PP, Shen L. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer. Oncotarget. 2014; 5: 6594-602. doi: 10.18632/oncotarget.2175.
    • (2014) Oncotarget , vol.5 , pp. 6594-6602
    • Li, Y.1    Zhang, X.2    Ge, S.3    Gao, J.4    Gong, J.5    Lu, M.6    Zhang, Q.7    Cao, Y.8    Wang, D.D.9    Lin, P.P.10    Shen, L.11
  • 176
  • 179
    • 0024478054 scopus 로고
    • p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
    • Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM, Ullrich A. p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol. 1989; 9: 1165-72.
    • (1989) Mol Cell Biol , vol.9 , pp. 1165-1172
    • Hudziak, R.M.1    Lewis, G.D.2    Winget, M.3    Fendly, B.M.4    Shepard, H.M.5    Ullrich, A.6
  • 181
    • 0024446195 scopus 로고
    • HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor
    • Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A. HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor. EMBO J. 1989; 8: 167-73. doi:
    • (1989) EMBO J , vol.8 , pp. 167-173
    • Lee, J.1    Dull, T.J.2    Lax, I.3    Schlessinger, J.4    Ullrich, A.5
  • 182
    • 26844559765 scopus 로고    scopus 로고
    • Trastuzumab in the treatment of breast cancer
    • Hortobagyi GN. Trastuzumab in the treatment of breast cancer. N Engl J Med. 2005; 353: 1734-6. doi: 10.1056/NEJMe058196.
    • (2005) N Engl J Med , vol.353 , pp. 1734-1736
    • Hortobagyi, G.N.1
  • 185
    • 84876697121 scopus 로고    scopus 로고
    • Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
    • Liu Y, Liu Q, Wang T, Bian L, Zhang S, Hu H, Li S, Hu Z, Wu S, Liu B, Jiang Z. Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker. BMC Cancer. 2013; 13: 202. doi: 10.1186/1471-2407-13-202.
    • (2013) BMC Cancer , vol.13 , pp. 202
    • Liu, Y.1    Liu, Q.2    Wang, T.3    Bian, L.4    Zhang, S.5    Hu, H.6    Li, S.7    Hu, Z.8    Wu, S.9    Liu, B.10    Jiang, Z.11
  • 187
    • 0026571910 scopus 로고
    • The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients
    • Klijn JG, Berns PM, Schmitz PI, Foekens JA. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev. 1992; 13: 3-17. doi: 10.1210/edrv-13-1-3.
    • (1992) Endocr Rev , vol.13 , pp. 3-17
    • Klijn, J.G.1    Berns, P.M.2    Schmitz, P.I.3    Foekens, J.A.4
  • 190
    • 36248968708 scopus 로고    scopus 로고
    • SnapShot: EGFR signaling pathway
    • Yarden Y, Shilo BZ. SnapShot: EGFR signaling pathway. Cell. 2007; 131: 1018. doi: 10.1016/j.cell.2007.11.013.
    • (2007) Cell , vol.131 , pp. 1018
    • Yarden, Y.1    Shilo, B.Z.2
  • 191
    • 0034722889 scopus 로고    scopus 로고
    • The EGF receptor family as targets for cancer therapy
    • Mendelsohn J, Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 2000; 19: 6550-65. doi: 10.1038/sj.onc.1204082.
    • (2000) Oncogene , vol.19 , pp. 6550-6565
    • Mendelsohn, J.1    Baselga, J.2
  • 192
    • 0018236378 scopus 로고
    • Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
    • Carpenter G, King L, Jr., Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature. 1978; 276: 409-10. doi:
    • (1978) Nature , vol.276 , pp. 409-410
    • Carpenter, G.1    King, L.2    Cohen, S.3
  • 193
    • 33745828702 scopus 로고    scopus 로고
    • EGF-ERBB signalling: towards the systems level
    • Citri A, Yarden Y. EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol. 2006; 7: 505-16. doi: 10.1038/nrm1962.
    • (2006) Nat Rev Mol Cell Biol , vol.7 , pp. 505-516
    • Citri, A.1    Yarden, Y.2
  • 194
    • 0034773992 scopus 로고    scopus 로고
    • The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities
    • Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer. 2001; 37 Suppl 4: S3-8. doi:
    • (2001) Eur J Cancer , vol.37 , pp. S3-S8
    • Yarden, Y.1
  • 196
    • 0035901570 scopus 로고    scopus 로고
    • Epidermal growth factor receptor signaling
    • Bogdan S, Klambt C. Epidermal growth factor receptor signaling. Curr Biol. 2001; 11: R292-5.
    • (2001) Curr Biol , vol.11 , pp. R292-R295
    • Bogdan, S.1    Klambt, C.2
  • 197
    • 33746561717 scopus 로고    scopus 로고
    • Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1
    • Lo HW, Ali-Seyed M, Wu Y, Bartholomeusz G, Hsu SC, Hung MC. Nuclear-cytoplasmic transport of EGFR involves receptor endocytosis, importin beta1 and CRM1. J Cell Biochem. 2006; 98: 1570-83. doi: 10.1002/jcb.20876.
    • (2006) J Cell Biochem , vol.98 , pp. 1570-1583
    • Lo, H.W.1    Ali-Seyed, M.2    Wu, Y.3    Bartholomeusz, G.4    Hsu, S.C.5    Hung, M.C.6
  • 198
    • 33645217263 scopus 로고    scopus 로고
    • EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization
    • Lo HW, Hsu SC, Hung MC. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res Treat. 2006; 95: 211-8. doi: 10.1007/s10549-005-9011-0.
    • (2006) Breast Cancer Res Treat , vol.95 , pp. 211-218
    • Lo, H.W.1    Hsu, S.C.2    Hung, M.C.3
  • 199
    • 31444440292 scopus 로고    scopus 로고
    • Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival
    • Lo HW, Hung MC. Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. Br J Cancer. 2006; 94: 184-8. doi: 10.1038/sj.bjc.6602941.
    • (2006) Br J Cancer , vol.94 , pp. 184-188
    • Lo, H.W.1    Hung, M.C.2
  • 200
  • 201
    • 84863868124 scopus 로고    scopus 로고
    • Regulated intramembrane cleavage of the EGF receptor
    • Liao HJ, Carpenter G. Regulated intramembrane cleavage of the EGF receptor. Traffic. 2012; 13: 1106-12. doi: 10.1111/j.1600-0854.2012.01371.x.
    • (2012) Traffic , vol.13 , pp. 1106-1112
    • Liao, H.J.1    Carpenter, G.2
  • 202
    • 51749089748 scopus 로고    scopus 로고
    • Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells
    • Perez-Torres M, Valle BL, Maihle NJ, Negron-Vega L, Nieves-Alicea R, Cora EM. Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells. Exp Cell Res. 2008; 314: 2907-18. doi: 10.1016/j.yexcr.2008.07.013.
    • (2008) Exp Cell Res , vol.314 , pp. 2907-2918
    • Perez-Torres, M.1    Valle, B.L.2    Maihle, N.J.3    Negron-Vega, L.4    Nieves-Alicea, R.5    Cora, E.M.6
  • 203
    • 41849147892 scopus 로고    scopus 로고
    • Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion
    • Sanderson MP, Keller S, Alonso A, Riedle S, Dempsey PJ, Altevogt P. Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretion. J Cell Biochem. 2008; 103: 1783-97. doi: 10.1002/jcb.21569.
    • (2008) J Cell Biochem , vol.103 , pp. 1783-1797
    • Sanderson, M.P.1    Keller, S.2    Alonso, A.3    Riedle, S.4    Dempsey, P.J.5    Altevogt, P.6
  • 204
    • 84872048462 scopus 로고    scopus 로고
    • Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer
    • Gasch C, Bauernhofer T, Pichler M, Langer-Freitag S, Reeh M, Seifert AM, Mauermann O, Izbicki JR, Pantel K, Riethdorf S. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem. 2013; 59: 252-60. doi: 10.1373/clinchem.2012.188557.
    • (2013) Clin Chem , vol.59 , pp. 252-260
    • Gasch, C.1    Bauernhofer, T.2    Pichler, M.3    Langer-Freitag, S.4    Reeh, M.5    Seifert, A.M.6    Mauermann, O.7    Izbicki, J.R.8    Pantel, K.9    Riethdorf, S.10
  • 205
  • 206
    • 84885000067 scopus 로고    scopus 로고
    • Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer
    • Kuboki Y, Matsusaka S, Minowa S, Shibata H, Suenaga M, Shinozaki E, Mizunuma N, Ueno M, Yamaguchi T, Hatake K. Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer. Anticancer Res. 2013; 33: 3905-10. doi:
    • (2013) Anticancer Res , vol.33 , pp. 3905-3910
    • Kuboki, Y.1    Matsusaka, S.2    Minowa, S.3    Shibata, H.4    Suenaga, M.5    Shinozaki, E.6    Mizunuma, N.7    Ueno, M.8    Yamaguchi, T.9    Hatake, K.10
  • 207
    • 62649109967 scopus 로고    scopus 로고
    • Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients
    • Payne RE, Yague E, Slade MJ, Apostolopoulos C, Jiao LR, Ward B, Coombes RC, Stebbing J. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. Pharmacogenomics. 2009; 10: 51-7. doi: 10.2217/14622416.10.1.51.
    • (2009) Pharmacogenomics , vol.10 , pp. 51-57
    • Payne, R.E.1    Yague, E.2    Slade, M.J.3    Apostolopoulos, C.4    Jiao, L.R.5    Ward, B.6    Coombes, R.C.7    Stebbing, J.8
  • 208
    • 84898057920 scopus 로고    scopus 로고
    • Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
    • Kalykaki A, Agelaki S, Kallergi G, Xyrafas A, Mavroudis D, Georgoulias V. Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib. Cancer Chemother Pharmacol. 2014; 73: 685-93. doi: 10.1007/s00280-014-2387-y.
    • (2014) Cancer Chemother Pharmacol , vol.73 , pp. 685-693
    • Kalykaki, A.1    Agelaki, S.2    Kallergi, G.3    Xyrafas, A.4    Mavroudis, D.5    Georgoulias, V.6
  • 211
    • 0027303279 scopus 로고
    • CD44 splice variants: metastases meet lymphocytes
    • Herrlich P, Zoller M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today. 1993; 14: 395-9. doi: 10.1016/0167-5699(93)90141-7.
    • (1993) Immunol Today , vol.14 , pp. 395-399
    • Herrlich, P.1    Zoller, M.2    Pals, S.T.3    Ponta, H.4
  • 214
    • 0037227965 scopus 로고    scopus 로고
    • CD44: from adhesion molecules to signalling regulators
    • Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003; 4: 33-45.
    • (2003) Nat Rev Mol Cell Biol , vol.4 , pp. 33-45
    • Ponta, H.1    Sherman, L.2    Herrlich, P.A.3
  • 215
    • 0026446637 scopus 로고
    • CD44: the hyaluronan receptor
    • Underhill C. CD44: the hyaluronan receptor. J Cell Sci. 1992; 103 (Pt 2): 293-8.
    • (1992) J Cell Sci , vol.103 , pp. 293-298
    • Underhill, C.1
  • 216
  • 217
    • 70350362953 scopus 로고    scopus 로고
    • Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells
    • Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009; 284: 26533-46. doi: M109.027466 [pii]10.1074/jbc. M109.027466.
    • (2009) J Biol Chem , vol.284 , pp. 26533-26546
    • Bourguignon, L.Y.1    Spevak, C.C.2    Wong, G.3    Xia, W.4    Gilad, E.5
  • 218
    • 78449234396 scopus 로고    scopus 로고
    • Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
    • Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion. J Biol Chem. 2010; 285: 36721-35. doi: M110.162305 [pii]10.1074/jbc. M110.162305.
    • (2010) J Biol Chem , vol.285 , pp. 36721-36735
    • Bourguignon, L.Y.1    Wong, G.2    Earle, C.3    Krueger, K.4    Spevak, C.C.5
  • 219
    • 59149085705 scopus 로고    scopus 로고
    • Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates betacatenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells
    • Bourguignon LY, Xia W, Wong G. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates betacatenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem. 2009; 284: 2657-71. doi: M806708200 [pii]10.1074/jbc. M806708200.
    • (2009) J Biol Chem , vol.284 , pp. 2657-2671
    • Bourguignon, L.Y.1    Xia, W.2    Wong, G.3
  • 220
    • 19344377475 scopus 로고    scopus 로고
    • CD44v6 promotes proliferation by persisting activation of MAP kinases
    • Marhaba R, Bourouba M, Zoller M. CD44v6 promotes proliferation by persisting activation of MAP kinases. Cell Signal. 2005; 17: 961-73.
    • (2005) Cell Signal , vol.17 , pp. 961-973
    • Marhaba, R.1    Bourouba, M.2    Zoller, M.3
  • 224
    • 77949891635 scopus 로고    scopus 로고
    • Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma
    • Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J. Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma. Int J Cancer. 2010; 126: 2067-78. doi: 10.1002/ijc.24868.
    • (2010) Int J Cancer , vol.126 , pp. 2067-2078
    • Zhu, Z.1    Hao, X.2    Yan, M.3    Yao, M.4    Ge, C.5    Gu, J.6    Li, J.7
  • 228
    • 44749091840 scopus 로고    scopus 로고
    • Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
    • Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol. 2008; 18: 260-7.
    • (2008) Semin Cancer Biol , vol.18 , pp. 260-267
    • Naor, D.1    Wallach-Dayan, S.B.2    Zahalka, M.A.3    Sionov, R.V.4
  • 229
    • 33749515476 scopus 로고    scopus 로고
    • Targeting of CD44 eradicates human acute myeloid leukemic stem cells
    • nm1483 [pii]
    • Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med. 2006; 12: 1167-74. doi: nm1483 [pii]10.1038/nm1483.
    • (2006) Nat Med , vol.12 , pp. 1167-1174
    • Jin, L.1    Hope, K.J.2    Zhai, Q.3    Smadja-Joffe, F.4    Dick, J.E.5
  • 230
    • 80054061816 scopus 로고    scopus 로고
    • CD44 and HCELL: preventing hematogenous metastasis at step 1
    • Jacobs PP, Sackstein R. CD44 and HCELL: preventing hematogenous metastasis at step 1. FEBS Lett. 2011; 585: 3148-58. doi: 10.1016/j.febslet.2011.07.039.
    • (2011) FEBS Lett , vol.585 , pp. 3148-3158
    • Jacobs, P.P.1    Sackstein, R.2
  • 231
    • 33744920615 scopus 로고    scopus 로고
    • HCELL is the major E-and L-selectin ligand expressed on LS174T colon carcinoma cells
    • Burdick MM, Chu JT, Godar S, Sackstein R. HCELL is the major E-and L-selectin ligand expressed on LS174T colon carcinoma cells. J Biol Chem. 2006; 281: 13899-905. doi: 10.1074/jbc. M513617200.
    • (2006) J Biol Chem , vol.281 , pp. 13899-13905
    • Burdick, M.M.1    Chu, J.T.2    Godar, S.3    Sackstein, R.4
  • 235
    • 84855860082 scopus 로고    scopus 로고
    • HGF/c-MET targeted therapeutics: novel strategies for cancer medicine
    • Yap TA, Sandhu SK, Alam SM, de Bono JS. HGF/c-MET targeted therapeutics: novel strategies for cancer medicine. Curr Drug Targets. 2011; 12: 2045-58.
    • (2011) Curr Drug Targets , vol.12 , pp. 2045-2058
    • Yap, T.A.1    Sandhu, S.K.2    Alam, S.M.3    de Bono, J.S.4
  • 237
    • 84908108434 scopus 로고    scopus 로고
    • Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling
    • van Noort V, Scholch S, Iskar M, Zeller G, Ostertag K, Schweitzer C, Werner K, Weitz J, Koch M, Bork P. Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling. Cancer Res. 2014; 74: 5690-9. doi: 10.1158/0008-5472. CAN-13-3540.
    • (2014) Cancer Res , vol.74 , pp. 5690-5699
    • van Noort, V.1    Scholch, S.2    Iskar, M.3    Zeller, G.4    Ostertag, K.5    Schweitzer, C.6    Werner, K.7    Weitz, J.8    Koch, M.9    Bork, P.10
  • 238
    • 84941711371 scopus 로고    scopus 로고
    • Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future
    • Chen L, Han X. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future. J Clin Invest. 2015; 125: 3384-91. doi: 10.1172/JCI80011.
    • (2015) J Clin Invest , vol.125 , pp. 3384-3391
    • Chen, L.1    Han, X.2
  • 241
    • 0037126021 scopus 로고    scopus 로고
    • Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
    • Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A. 2002; 99: 12293-7. doi: 10.1073/pnas.192461099.
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 12293-12297
    • Iwai, Y.1    Ishida, M.2    Tanaka, Y.3    Okazaki, T.4    Honjo, T.5    Minato, N.6
  • 243
    • 0033991158 scopus 로고    scopus 로고
    • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance
    • Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol. 2000; 74: 181-273. doi:
    • (2000) Adv Immunol , vol.74 , pp. 181-273
    • Marincola, F.M.1    Jaffee, E.M.2    Hicklin, D.J.3    Ferrone, S.4
  • 246
    • 84938329177 scopus 로고    scopus 로고
    • PD-L1 and Survival in Solid Tumors: A Meta-Analysis
    • Wu P, Wu D, Li L, Chai Y, Huang J. PD-L1 and Survival in Solid Tumors: A Meta-Analysis. PLoS One. 2015; 10: e0131403. doi: 10.1371/journal.pone.0131403.
    • (2015) PLoS One , vol.10
    • Wu, P.1    Wu, D.2    Li, L.3    Chai, Y.4    Huang, J.5
  • 248
    • 84960438539 scopus 로고    scopus 로고
    • Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application
    • Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I. Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application. Int J Clin Oncol. 2016; 21: 456-61. doi: 10.1007/s10147-016-0968-y.
    • (2016) Int J Clin Oncol , vol.21 , pp. 456-461
    • Mandai, M.1    Hamanishi, J.2    Abiko, K.3    Matsumura, N.4    Baba, T.5    Konishi, I.6
  • 249
    • 84930730522 scopus 로고    scopus 로고
    • Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy
    • Swaika A, Hammond WA, Joseph RW. Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy. Mol Immunol. 2015; 67: 4-17. doi: 10.1016/j. molimm.2015.02.009.
    • (2015) Mol Immunol , vol.67 , pp. 4-17
    • Swaika, A.1    Hammond, W.A.2    Joseph, R.W.3
  • 251
    • 84942428540 scopus 로고    scopus 로고
    • PD-L1 expression by circulating breast cancer cells
    • David R. PD-L1 expression by circulating breast cancer cells. Lancet Oncol. 2015; 16: e321. doi: 10.1016/S1470-2045(15)00074-1.
    • (2015) Lancet Oncol , vol.16
    • David, R.1
  • 253
    • 84976877484 scopus 로고    scopus 로고
    • Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients
    • Satelli A, Batth IS, Brownlee Z, Rojas C, Meng QH, Kopetz S, Li S. Potential role of nuclear PD-L1 expression in cell-surface vimentin positive circulating tumor cells as a prognostic marker in cancer patients. Sci Rep. 2016; 6:28910 doi: 10.1038/srep28910.
    • (2016) Sci Rep , vol.6 , pp. 28910
    • Satelli, A.1    Batth, I.S.2    Brownlee, Z.3    Rojas, C.4    Meng, Q.H.5    Kopetz, S.6    Li, S.7
  • 255
    • 33748068119 scopus 로고    scopus 로고
    • The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis
    • Mocellin S, Hoon D, Ambrosi A, Nitti D, Rossi CR. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res. 2006; 12: 4605-13. doi: 10.1158/1078-0432. CCR-06-0823.
    • (2006) Clin Cancer Res , vol.12 , pp. 4605-4613
    • Mocellin, S.1    Hoon, D.2    Ambrosi, A.3    Nitti, D.4    Rossi, C.R.5
  • 258
    • 84899107449 scopus 로고    scopus 로고
    • Prognostic value of circulating tumor cells in patients with pancreatic cancer: a metaanalysis
    • Han L, Chen W, Zhao Q. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a metaanalysis. Tumour Biol. 2014; 35: 2473-80. doi: 10.1007/s13277-013-1327-5.
    • (2014) Tumour Biol , vol.35 , pp. 2473-2480
    • Han, L.1    Chen, W.2    Zhao, Q.3
  • 259
    • 84957602545 scopus 로고    scopus 로고
    • Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis
    • Wu XL, Tu Q, Faure G, Gallet P, Kohler C, Bittencourt Mde C. Diagnostic and Prognostic Value of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: a systematic review and meta-analysis. Sci Rep. 2016; 6:20210 doi: 10.1038/srep20210.
    • (2016) Sci Rep , vol.6 , pp. 20210
    • Wu, X.L.1    Tu, Q.2    Faure, G.3    Gallet, P.4    Kohler, C.5    Bittencourt Mde, C.6
  • 260
    • 84966473543 scopus 로고    scopus 로고
    • Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
    • Hyun KA, Goo KB, Han H, Sohn J, Choi W, Kim SI, Jung HI, Kim YS. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer. Oncotarget. 2016. doi: 10.18632/oncotarget.8250.
    • (2016) Oncotarget
    • Hyun, K.A.1    Goo, K.B.2    Han, H.3    Sohn, J.4    Choi, W.5    Kim, S.I.6    Jung, H.I.7    Kim, Y.S.8
  • 261
    • 73649125337 scopus 로고    scopus 로고
    • Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
    • Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D, Georgoulias V. Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett. 2010; 288: 99-106. doi: 10.1016/j.canlet.2009.06.027.
    • (2010) Cancer Lett , vol.288 , pp. 99-106
    • Theodoropoulos, P.A.1    Polioudaki, H.2    Agelaki, S.3    Kallergi, G.4    Saridaki, Z.5    Mavroudis, D.6    Georgoulias, V.7
  • 266
    • 75449106680 scopus 로고    scopus 로고
    • Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
    • Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 2009; 11: R46. doi: 10.1186/bcr2333.
    • (2009) Breast Cancer Res , vol.11 , pp. R46
    • Aktas, B.1    Tewes, M.2    Fehm, T.3    Hauch, S.4    Kimmig, R.5    Kasimir-Bauer, S.6
  • 267
    • 84971325358 scopus 로고    scopus 로고
    • Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment
    • Malara N, Trunzo V, Foresta U, Amodio N, De Vitis S, Roveda L, Fava M, Coluccio M, Macri R, Di Vito A, Costa N, Mignogna C, Britti D, et al. Ex-vivo characterization of circulating colon cancer cells distinguished in stem and differentiated subset provides useful biomarker for personalized metastatic risk assessment. J Transl Med. 2016; 14: 133. doi: 10.1186/s12967-016-0876-y.
    • (2016) J Transl Med , vol.14 , pp. 133
    • Malara, N.1    Trunzo, V.2    Foresta, U.3    Amodio, N.4    De Vitis, S.5    Roveda, L.6    Fava, M.7    Coluccio, M.8    Macri, R.9    Di Vito, A.10    Costa, N.11    Mignogna, C.12    Britti, D.13
  • 269
    • 84863043341 scopus 로고    scopus 로고
    • Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients
    • Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol Rep. 2012; 27: 947-53. doi: 10.3892/or.2012.1649.
    • (2012) Oncol Rep , vol.27 , pp. 947-953
    • Shimada, R.1    Iinuma, H.2    Akahane, T.3    Horiuchi, A.4    Watanabe, T.5
  • 270
    • 84927150847 scopus 로고    scopus 로고
    • Individual profiling of circulating tumor cell composition in patients with nonsmall cell lung cancer receiving platinum based treatment
    • Nel I, Jehn U, Gauler T, Hoffmann AC. Individual profiling of circulating tumor cell composition in patients with nonsmall cell lung cancer receiving platinum based treatment. Transl Lung Cancer Res. 2014; 3: 100-6. doi: 10.3978/j. issn.2218-6751.2014.03.05.
    • (2014) Transl Lung Cancer Res , vol.3 , pp. 100-106
    • Nel, I.1    Jehn, U.2    Gauler, T.3    Hoffmann, A.C.4
  • 271
    • 84876111096 scopus 로고    scopus 로고
    • Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
    • Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology. 2013; 57: 1458-68. doi: 10.1002/hep.26151.
    • (2013) Hepatology , vol.57 , pp. 1458-1468
    • Sun, Y.F.1    Xu, Y.2    Yang, X.R.3    Guo, W.4    Zhang, X.5    Qiu, S.J.6    Shi, R.Y.7    Hu, B.8    Zhou, J.9    Fan, J.10
  • 273
    • 84860571431 scopus 로고    scopus 로고
    • EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients
    • Alix-Panabieres C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 2012; 195: 69-76. doi: 10.1007/978-3-642-28160-0_6.
    • (2012) Recent Results Cancer Res , vol.195 , pp. 69-76
    • Alix-Panabieres, C.1
  • 275
    • 84945454788 scopus 로고    scopus 로고
    • Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas
    • Kubisch I, de Albuquerque A, Schuppan D, Kaul S, Schaich M, Stolzel U. Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas. Oncology. 2015; 89: 294-303. doi: 10.1159/000437373.
    • (2015) Oncology , vol.89 , pp. 294-303
    • Kubisch, I.1    de Albuquerque, A.2    Schuppan, D.3    Kaul, S.4    Schaich, M.5    Stolzel, U.6
  • 276
    • 84858672404 scopus 로고    scopus 로고
    • Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine
    • de Albuquerque A, Kaul S, Breier G, Krabisch P, Fersis N. Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine. Breast Care (Basel). 2012; 7: 7-12. doi: 10.1159/000336548.
    • (2012) Breast Care (Basel) , vol.7 , pp. 7-12
    • de Albuquerque, A.1    Kaul, S.2    Breier, G.3    Krabisch, P.4    Fersis, N.5
  • 278
    • 84939563058 scopus 로고    scopus 로고
    • Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry
    • Lu Y, Liang H, Yu T, Xie J, Chen S, Dong H, Sinko PJ, Lian S, Xu J, Wang J, Yu S, Shao J, Yuan B, et al. Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry. Cancer. 2015; 121: 3036-45. doi: 10.1002/cncr.29444.
    • (2015) Cancer , vol.121 , pp. 3036-3045
    • Lu, Y.1    Liang, H.2    Yu, T.3    Xie, J.4    Chen, S.5    Dong, H.6    Sinko, P.J.7    Lian, S.8    Xu, J.9    Wang, J.10    Yu, S.11    Shao, J.12    Yuan, B.13
  • 279
    • 80052795481 scopus 로고    scopus 로고
    • Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy
    • Aktas B, Kasimir-Bauer S, Heubner M, Kimmig R, Wimberger P. Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy. Int J Gynecol Cancer. 2011; 21: 822-30. doi: 10.1097/IGC.0b013e318216cb91.
    • (2011) Int J Gynecol Cancer , vol.21 , pp. 822-830
    • Aktas, B.1    Kasimir-Bauer, S.2    Heubner, M.3    Kimmig, R.4    Wimberger, P.5
  • 280
    • 84863984494 scopus 로고    scopus 로고
    • Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
    • Pestrin M, Bessi S, Puglisi F, Minisini AM, Masci G, Battelli N, Ravaioli A, Gianni L, Di Marsico R, Tondini C, Gori S, Coombes CR, Stebbing J, et al. Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study. Breast Cancer Res Treat. 2012; 134: 283-9. doi: 10.1007/s10549-012-2045-1.
    • (2012) Breast Cancer Res Treat , vol.134 , pp. 283-289
    • Pestrin, M.1    Bessi, S.2    Puglisi, F.3    Minisini, A.M.4    Masci, G.5    Battelli, N.6    Ravaioli, A.7    Gianni, L.8    Di Marsico, R.9    Tondini, C.10    Gori, S.11    Coombes, C.R.12    Stebbing, J.13
  • 282
    • 54249145112 scopus 로고    scopus 로고
    • Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells
    • Lankiewicz S, Rother E, Zimmermann S, Hollmann C, Korangy F, Greten TF. Tumour-associated transcripts and EGFR deletion variants in colorectal cancer in primary tumour, metastases and circulating tumour cells. Cell Oncol. 2008; 30: 463-71.
    • (2008) Cell Oncol , vol.30 , pp. 463-471
    • Lankiewicz, S.1    Rother, E.2    Zimmermann, S.3    Hollmann, C.4    Korangy, F.5    Greten, T.F.6
  • 287
    • 84877144549 scopus 로고    scopus 로고
    • The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study
    • Stebbing J, Payne R, Reise J, Frampton AE, Avery M, Woodley L, Di Leo A, Pestrin M, Krell J, Coombes RC. The efficacy of lapatinib in metastatic breast cancer with HER2 non-amplified primary tumors and EGFR positive circulating tumor cells: a proof-of-concept study. PLoS One. 2013; 8: e62543. doi: 10.1371/journal.pone.0062543.
    • (2013) PLoS One , vol.8
    • Stebbing, J.1    Payne, R.2    Reise, J.3    Frampton, A.E.4    Avery, M.5    Woodley, L.6    Di Leo, A.7    Pestrin, M.8    Krell, J.9    Coombes, R.C.10
  • 291
    • 84942086661 scopus 로고    scopus 로고
    • A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus
    • Ma Y, Hao S, Wang S, Zhao Y, Lim B, Lei M, Spector DJ, El-Deiry WS, Zheng SY, Zhu J. A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus. Mol Cancer Ther. 2015; 14: 835-43. doi: 10.1158/1535-7163.MCT-14-0693.
    • (2015) Mol Cancer Ther , vol.14 , pp. 835-843
    • Ma, Y.1    Hao, S.2    Wang, S.3    Zhao, Y.4    Lim, B.5    Lei, M.6    Spector, D.J.7    El-Deiry, W.S.8    Zheng, S.Y.9    Zhu, J.10
  • 294
    • 84942980741 scopus 로고    scopus 로고
    • Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay
    • Wang HY, Ahn S, Kim S, Park S, Jung D, Park S, Han H, Sohn J, Kim S, Lee H. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay. Int J Clin Oncol. 2015; 20: 878-90. doi: 10.1007/s10147-015-0798-3.
    • (2015) Int J Clin Oncol , vol.20 , pp. 878-890
    • Wang, H.Y.1    Ahn, S.2    Kim, S.3    Park, S.4    Jung, D.5    Park, S.6    Han, H.7    Sohn, J.8    Kim, S.9    Lee, H.10
  • 297
    • 84948808509 scopus 로고    scopus 로고
    • The isolation and characterization of CTC subsets related to breast cancer dormancy
    • Vishnoi M, Peddibhotla S, Yin W, A TS, George GC, Hong DS, Marchetti D. The isolation and characterization of CTC subsets related to breast cancer dormancy. Sci Rep. 2015; 5:17533 doi: 10.1038/srep17533.
    • (2015) Sci Rep , vol.5 , pp. 17533
    • Vishnoi, M.1    Peddibhotla, S.2    Yin, W.A.T.S.3    George, G.C.4    Hong, D.S.5    Marchetti, D.6
  • 299
    • 33750306612 scopus 로고    scopus 로고
    • Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
    • Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006; 12: 5615-21. doi: 10.1158/1078-0432.CCR-06-0169.
    • (2006) Clin Cancer Res , vol.12 , pp. 5615-5621
    • Balic, M.1    Lin, H.2    Young, L.3    Hawes, D.4    Giuliano, A.5    McNamara, G.6    Datar, R.H.7    Cote, R.J.8
  • 300
    • 84872054940 scopus 로고    scopus 로고
    • The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer
    • Wu P, Tang RN, Zou JH, Wang FC. The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer. Hepatogastroenterology. 2012; 59: 2164-7. doi: 10.5754/hge12539.
    • (2012) Hepatogastroenterology , vol.59 , pp. 2164-2167
    • Wu, P.1    Tang, R.N.2    Zou, J.H.3    Wang, F.C.4
  • 301
    • 84861448522 scopus 로고    scopus 로고
    • Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome
    • Tjensvoll K, Oltedal S, Heikkila R, Kvaloy JT, Gilje B, Reuben JM, Smaaland R, Nordgard O. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome. BMC Cancer. 2012; 12: 190. doi: 10.1186/1471-2407-12-190.
    • (2012) BMC Cancer , vol.12 , pp. 190
    • Tjensvoll, K.1    Oltedal, S.2    Heikkila, R.3    Kvaloy, J.T.4    Gilje, B.5    Reuben, J.M.6    Smaaland, R.7    Nordgard, O.8
  • 302
    • 84904087284 scopus 로고    scopus 로고
    • Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients
    • Gilje B, Nordgard O, Tjensvoll K, Borgen E, Synnestvedt M, Smaaland R, Naume B. Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients. BMC Cancer. 2014; 14: 514. doi: 10.1186/1471-2407-14-514.
    • (2014) BMC Cancer , vol.14 , pp. 514
    • Gilje, B.1    Nordgard, O.2    Tjensvoll, K.3    Borgen, E.4    Synnestvedt, M.5    Smaaland, R.6    Naume, B.7
  • 303
    • 67650457467 scopus 로고    scopus 로고
    • Urokinase-plasminogenactivator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer
    • Thomas C, Wiesner C, Melchior SW, Schmidt F, Gillitzer R, ThuroffJW, Pfitzenmaier J. Urokinase-plasminogenactivator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer. BJU Int. 2009; 104: 29-34. doi: 10.1111/j.1464-410X.2008.08298.x.
    • (2009) BJU Int , vol.104 , pp. 29-34
    • Thomas, C.1    Wiesner, C.2    Melchior, S.W.3    Schmidt, F.4    Gillitzer, R.5    Thuroff, J.W.6    Pfitzenmaier, J.7
  • 304
    • 23744466035 scopus 로고    scopus 로고
    • Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen
    • Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K. Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen. Histochem Cell Biol. 2005; 123: 631-7. doi: 10.1007/s00418-005-0781-6.
    • (2005) Histochem Cell Biol , vol.123 , pp. 631-637
    • Schindlbeck, C.1    Jeschke, U.2    Schulze, S.3    Karsten, U.4    Janni, W.5    Rack, B.6    Sommer, H.7    Friese, K.8
  • 305
    • 34548693895 scopus 로고    scopus 로고
    • Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow
    • Schindlbeck C, Hantschmann P, Zerzer M, Jahns B, Rjosk D, Janni W, Rack B, Sommer H, Friese K. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow. Int J Gynecol Cancer. 2007; 17: 1047-55. doi: 10.1111/j.1525-1438.2007.00920.x.
    • (2007) Int J Gynecol Cancer , vol.17 , pp. 1047-1055
    • Schindlbeck, C.1    Hantschmann, P.2    Zerzer, M.3    Jahns, B.4    Rjosk, D.5    Janni, W.6    Rack, B.7    Sommer, H.8    Friese, K.9
  • 306
    • 34547743433 scopus 로고    scopus 로고
    • Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
    • Schindlbeck C, Kampik T, Janni W, Rack B, Jeschke U, Krajewski S, Sommer H, Friese K. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas. Breast Cancer Res. 2005; 7: R1174-85. doi: 10.1186/bcr1360.
    • (2005) Breast Cancer Res , vol.7 , pp. R1174-R1185
    • Schindlbeck, C.1    Kampik, T.2    Janni, W.3    Rack, B.4    Jeschke, U.5    Krajewski, S.6    Sommer, H.7    Friese, K.8
  • 308
    • 0035266243 scopus 로고    scopus 로고
    • ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients
    • Braun S, Schlimok G, Heumos I, Schaller G, Riethdorf L, Riethmuller G, Pantel K. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res. 2001; 61: 1890-5.
    • (2001) Cancer Res , vol.61 , pp. 1890-1895
    • Braun, S.1    Schlimok, G.2    Heumos, I.3    Schaller, G.4    Riethdorf, L.5    Riethmuller, G.6    Pantel, K.7
  • 310
    • 0037348473 scopus 로고    scopus 로고
    • Antigenic profiles of disseminated breast tumour cells and microenvironment in bone marrow
    • Zhang J, Shen KW, Liu G, Zhou J, Shen Q, Shen ZZ, Shao ZM. Antigenic profiles of disseminated breast tumour cells and microenvironment in bone marrow. Eur J Surg Oncol. 2003; 29: 121-6.
    • (2003) Eur J Surg Oncol , vol.29 , pp. 121-126
    • Zhang, J.1    Shen, K.W.2    Liu, G.3    Zhou, J.4    Shen, Q.5    Shen, Z.Z.6    Shao, Z.M.7
  • 315
    • 79651470120 scopus 로고    scopus 로고
    • The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR
    • Dardaei L, Shahsavani R, Ghavamzadeh A, Behmanesh M, Aslankoohi E, Alimoghaddam K, Ghaffari SH. The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR. Clin Biochem. 2011; 44: 325-30. doi: 10.1016/j. clinbiochem.2010.11.005.
    • (2011) Clin Biochem , vol.44 , pp. 325-330
    • Dardaei, L.1    Shahsavani, R.2    Ghavamzadeh, A.3    Behmanesh, M.4    Aslankoohi, E.5    Alimoghaddam, K.6    Ghaffari, S.H.7
  • 319
    • 35348857113 scopus 로고    scopus 로고
    • Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer
    • Wimberger P, Heubner M, Otterbach F, Fehm T, Kimmig R, Kasimir-Bauer S. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer. Gynecol Oncol. 2007; 107: 331-8. doi: 10.1016/j.ygyno.2007.07.073.
    • (2007) Gynecol Oncol , vol.107 , pp. 331-338
    • Wimberger, P.1    Heubner, M.2    Otterbach, F.3    Fehm, T.4    Kimmig, R.5    Kasimir-Bauer, S.6
  • 320
    • 0033398990 scopus 로고    scopus 로고
    • Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow
    • Braun S, Hepp F, Kentenich CR, Janni W, Pantel K, Riethmuller G, Willgeroth F, Sommer HL. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin Cancer Res. 1999; 5: 3999-4004.
    • (1999) Clin Cancer Res , vol.5 , pp. 3999-4004
    • Braun, S.1    Hepp, F.2    Kentenich, C.R.3    Janni, W.4    Pantel, K.5    Riethmuller, G.6    Willgeroth, F.7    Sommer, H.L.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.